This HTML5 document contains 76 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n15https://finance.yahoo.com/quote/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n21https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n12https://www.invitae.com/en/
n19https://www.google.com/finance/quote/NVTA:
n7https://www.invitae.com/
n14http://commons.wikimedia.org/wiki/Special:FilePath/
n22https://www.nyse.com/quote/XNYS:
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Invitae
rdf:type
n13:Agent n13:SocialPerson dbo:Agent wikidata:Q43229 owl:Thing wikidata:Q4830453 schema:Organization dbo:Company dbo:Organisation wikidata:Q24229398
rdfs:label
Invitae
rdfs:comment
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
foaf:name
Invitae Corp.
foaf:homepage
n7:en
dbp:name
Invitae Corp.
foaf:depiction
n14:Invitae-logo.png
dcterms:subject
dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:Research_support_companies dbc:Microarrays
dbo:wikiPageID
1666393
dbo:wikiPageRevisionID
1099089388
dbo:wikiPageWikiLink
dbr:Mukilteo,_Washington dbr:Acacia_Research_Corporation dbr:Postnatal dbr:Oncology dbr:Pediatric dbr:Prenatal_diagnosis dbr:Genomic_Health dbr:United_States_Department_of_Defense dbr:Genetic_testing dbr:San_Francisco,_California dbr:Chief_executive_officer dbc:Research_support_companies dbc:Microarrays dbr:Human_genome_sequence_map dbr:Combinatorial_chemistry dbr:Caltech dbr:Miscarriage dbc:Companies_listed_on_the_New_York_Stock_Exchange dbr:Single-nucleotide_polymorphism dbr:Corporate_spin-off
dbo:wikiPageExternalLink
n12: n15:nvta n7:en n19:NYSE n22:NVTA
owl:sameAs
wikidata:Q5150796 n21:4i1bp
dbp:wikiPageUsesTemplate
dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Missing_information dbt:Start_date_and_age dbt:Citation_needed
dbo:thumbnail
n14:Invitae-logo.png?width=300
dbp:hqLocation
San Francisco, California, U.S.
dbp:industry
Genetic testing
dbp:keyPeople
Kenneth D. Knight
dbp:logo
Invitae-logo.png
dbp:netIncome
-US$608.9 million
dbp:revenue
2.796E8
dbp:revenueYear
2020
dbp:tradedAs
NYSE:NVTA
dbp:website
n7:en
dbo:abstract
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
dbp:netIncomeYear
2020
prov:wasDerivedFrom
wikipedia-en:Invitae?oldid=1099089388&ns=0
dbo:wikiPageLength
10593
dbo:foundingYear
2010-01-01
dbo:netIncome
6.089E8
dbo:revenue
2.796E8
dbo:revenueYear
2020-01-01
dbo:headquarter
dbr:San_Francisco,_California
dbo:industry
dbr:Genetic_testing
dbo:keyPerson
dbr:Chief_executive_officer
foaf:isPrimaryTopicOf
wikipedia-en:Invitae